National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi and M/s Chaturbhuj Pharmaceutical Co, Haridwar have entered into License Agreement for commercialization of Ayush-82, an ayurvedic Formulation for management of Diabetes. Chairman & Managing Director, Dr. H. Purushotham NRDC said that Ayush-82 was developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous Organisation under the Ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy). The Licence agreement was signed by Dr. H. Purushotham , CMD , on behalf of National Research Development Corporation, New Delhi and Shri Murari Sharma, Proprietor, Chaturbhuj Pharmaceutical Co , Haridwar. National Research Development Corporation has so far licensed 13 Ayurvedic technologies developed by CCRAS to more than 33 companies in India.
Ayush-82; an anti diabetic drug developed by CCRAS is a combination of known and tested hypoglycemic drugs. Its clinical studies have been done extensively. Diabetes mellitus is a group of metabolic diseases marked by high level of blood glucose resulting from defects in insulin production, insulin action or both. Diabetes may lead to serious complications in multiple organ systems. The use of this cost effective drug would help millions of people suffering from Diabetes.
Powered by Capital Market - Live News
